Recap: Arrowhead Pharmaceuticals Q1 Earnings

Arrowhead Pharmaceuticals ARWR reported its Q1 earnings results on Wednesday, February 2, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Arrowhead Pharmaceuticals missed estimated earnings by 33.33%, reporting an EPS of $-0.6 versus an estimate of $-0.45, which surprised analysts.

Revenue was up $6.14 million from the same period last year.

Last quarter the company missed on EPS by $0.51, which was followed by a 2.32% increase in the share price the next day.

Here's a look at Arrowhead Pharmaceuticals's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.10	-0.20	-0.13	0.17
EPS Actual	-0.61	-0.29	-0.26	-0.20
Revenue Estimate	56.77M	37.52M	37.70M	86.69M
Revenue Actual	38.28M	45.89M	32.81M	21.30M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar